Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 4Urinary Bladder Neoplasms 3Urologic Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Pain, Postoperative 1Non-Muscle Invasive Bladder Neoplasms 1Erectile Dysfunction 1Carcinoma, Transitional Cell 1

Interventions

aldesleukin 43Sunitinib 42Cyclophosphamide 30Nivolumab 29pembrolizumab 27Everolimus 27Interferon-alpha 25Bevacizumab 23Sorafenib 22Interleukin-2 20fludarabine phosphate 19Radiotherapy 18Ipilimumab 18Filgrastim 18Axitinib 18Gene Expression Profiling 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14Radiosurgery 13fludarabine 11Doxorubicin 11Carboplatin 11Blood Specimen Collection 11temsirolimus 10atezolizumab 9Immunohistochemistry 9Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Kidney Neoplasms × Saline Solution × Genitourinary × Clear all
NCT03824808 2023-10-25

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

University of Missouri-Columbia

Phase 4 Terminated
21 enrolled 12 charts
Genitourinary

Kidney Neoplasms, Prostatic Neoplasms

NCT04162834 2021-04-19

Effect of Papaverine on Renal Artery Blood Flow Volume

Asan Medical Center

Phase 4 Completed
96 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡